1-(4′-Sulfophenyl)-3-carboxy-5-pyrazolone | CAS:118-47-8

We serve 1-(4′-Sulfophenyl)-3-carboxy-5-pyrazolone CAS:118-47-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-(4'-Sulfophenyl)-3-carboxy-5-pyrazolone

Chemical Name: 1-(4'-Sulfophenyl)-3-carboxy-5-pyrazolone
CAS.NO:118-47-8
Synonyms:3-Carboxy-1-(4-sulfophenyl)-2-pyrazolin-5-one;5-Oxo-1-(4-sulfophenyl)-2,5-dihydro-1H-pyrazole-3-carboxylic acid;4-(4-sulfo-1-phenylazo)-1-(4-sulfophenyl)-5-hydroxy-pyrazolone-3-carboxylic acid;5-oxo-1-(4-sulphophenyl)-4,5-dihydro-1H-pyrazole-3-carboxylic acid
Molecular Formula:C10H8N2O6S
Molecular Weight: 284.24500
 
Physical and Chemical Properties:
Density:1.75 g/cm3
Boiling point:/
Melting point:260-270ºC (Decomposes)
Flash point:/
Index of Refraction:1.695
 
Specification:
Appearance:Light yellow crystalline powder
Purity:≥99.0%
 
Packing: 25kg drum
Storage:Storage conditions:-20°C.This product should be sealed in a cool dry place.
Application:It is mainly used as a coupling component for organic synthetic dyes and pigment varieties.



Contact us for information like 1-(4′-Sulfophenyl)-3-carboxy-5-pyrazolone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-oxo-1-(4-sulphophenyl)-4,5-dihydro-1H-pyrazole-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(4-sulfo-1-phenylazo)-1-(4-sulfophenyl)-5-hydroxy-pyrazolone-3-carboxylic acid Use and application,5-Oxo-1-(4-sulfophenyl)-2,5-dihydro-1H-pyrazole-3-carboxylic acid technical grade,usp/ep/jp grade.


Related News: The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.2-Bromo-6-fluorotoluene manufacturer Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.3,5-Dimethylpyrazole supplier Others — somewhat more cynically — wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.Morpholinosulfur trifluoride vendor With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.What remains unknown is how exactly this nCoV came about and how easily it could spread, with researchers at Imperial College London suggesting on 20 January there could have been more than 1,700 cases in Wuhan alone by that point, when Chinese authorities were reporting just 62.